• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Alternative Treatments and In-Office Samples for Atopic Dermatitis Management

Author(s):

Andrea Rosik, PA-C

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

      Subscribe Now!
      Related Videos
      How OX40-Targeted Therapies Might Reshape Biologic Strategy in AD
      How OX40-Targeted Therapies Might Reshape Biologic Strategy in AD
      Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
      Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
      Understanding the Role of OX40 in Next-Generation Eczema Therapies
      Understanding the Role of OX40 in Next-Generation Eczema Therapies
      Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
      Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
      The Vicious Cycle of Itch, Stress, and Sleep Loss
      The Vicious Cycle of Itch, Stress, and Sleep Loss
      Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
      Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
      1 expert in this video
      Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management
      1 expert in this video
      Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice
      1 expert in this video
      Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments
      1 expert in this video
      Evaluating the Impact of Topical JAK Inhibitors on Pediatric Atopic Dermatitis Guidelines
      Related Content
      Switching Gears in Atopic Dermatitis: How Upadacitinib Helps Patients Reach Optimal Targets After Dupilumab Inadequacy
      May 8th 2025

      Switching Gears in Atopic Dermatitis: How Upadacitinib Helps Patients Reach Optimal Targets After Dupilumab Inadequacy

      Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
      March 31st 2025

      Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine

      Abrocitinib Shows Age-Linked Safety Differences
      May 8th 2025

      Abrocitinib Shows Age-Linked Safety Differences

      The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
      August 2nd 2024

      The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

      Upadacitinib Shows Promise in Reducing Cardiovascular and Thrombotic Risks in Atopic Dermatitis Patients
      May 6th 2025

      Upadacitinib Shows Promise in Reducing Cardiovascular and Thrombotic Risks in Atopic Dermatitis Patients

      Peter Lio, MD, Advocates for Personalized Pediatric Dermatology
      May 5th 2025

      Peter Lio, MD, Advocates for Personalized Pediatric Dermatology

      © 2025 MJH Life Sciences

      All rights reserved.